Newsfeeds - Spark Newswire

1 minute read

Lineage Cell Therapeutics Q4 EPS $(0.03) Beats $(0.04) Estimate, Sales $1.90M Miss $2.57M Estimate

Today, 5:13 PM

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 82.35 percent increase over losses of $(0.17) per share

LCTX

10 minute read

Earnings

Earnings Scheduled For March 9, 2023

By Benzinga Insights

Today, 5:13 PM

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.

ACHR

1 minute read

Lineage Cell Therapeutics Q3 EPS $(0.04) Misses $(0.03) Estimate, Sales $3.00M Miss $3.90M Estimate

By Benzinga Newsdesk

Today, 5:13 PM

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 20 percent increase over losses of $(0.05) per share

LCTX

1 minute read

Earnings

Earnings Preview: Lineage Cell Therapeutics

By Benzinga Insights

Today, 5:13 PM

Lineage Cell Therapeutics (AMEX:LCTX) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.03.

LCTX

1 minute read

Baird Initiates Coverage On Lineage Cell Therapeutics with Outperform Rating, Announces Price Target of $5

By Benzinga Newsdesk

Today, 5:13 PM

Baird analyst Jack Allen initiates coverage on Lineage Cell Therapeutics (AMEX:LCTX) with a Outperform rating and announces Price Target of $5.

LCTX

30 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 5:13 PM

During Wednesday's trading, 517 companies set new 52-week lows.

$APE

2 minute read

News

Lineage Announces Notice Of Allowance Of Two Patents Covering Processes For Manufacturing Allogeneic Oligodendrocyte Progenitor And Retinal Pigmented Epithelium Cells

By Benzinga Newsdesk

Today, 5:13 PM

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that the United States Patent and

LCTX

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

Today, 5:13 PM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG